HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum prolactin levels in women with gross cystic breast disease.

Abstract
Serum prolactin (PRL) concentrations at baseline and after TRH stimulation were determined in 15 healthy women and in 51 premenopausal patients suffering from Gross Cystic Breast Disease. All women were in the luteal phase of the menstrual cycle and patients were divided into three groups according to cyst type at presentation. Basal hormone levels were within the normal range in the control group and in the three cystic breast disease groups. The maximum PRL response to TRH stimulation was significantly higher (p < 0.001) in patients with type I cysts (low Na+/K+ intracystic ratio and apocrine epithelium) than in patients with type II cysts (high Na+/K+ intracystic ratio and flattened epithelium), type III cysts (intermediate Na+/K+ intracystic ratio and mixed epithelium) and in normal women. Serum PRL concentrations corresponding to samples obtained 60 and 90 minutes after stimulation remained higher in the first group of patients. These results led us to consider the existence of an altered central regulation of PRL secretion in patients with type I cysts at presentation.
AuthorsF Vizoso, M T Allende, J L García-Muñiz, E Alexandre, A Fueyo, A Ruibal
JournalThe International journal of biological markers (Int J Biol Markers) 1992 Oct-Dec Vol. 7 Issue 4 Pg. 225-9 ISSN: 0393-6155 [Print] United States
PMID1491178 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Thyrotropin-Releasing Hormone
  • Prolactin
Topics
  • Adult
  • Biomarkers (blood)
  • Female
  • Fibrocystic Breast Disease (blood, classification, diagnosis)
  • Humans
  • Luteal Phase
  • Middle Aged
  • Prolactin (blood, metabolism)
  • Thyrotropin-Releasing Hormone

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: